These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 783214)

  • 1. Drug metabolism in liver disease.
    Prescott LF; Forrest JA; Adjepon-Yamoah KK; Finlayson ND
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():62-5. PubMed ID: 783214
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Antipyrine, lingocaine and paracetamol metabolism in chronic liver disease.
    Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
    Gut; 1975 Oct; 16(10):828-9. PubMed ID: 1205294
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver disease and drug therapy.
    Black M
    Med Clin North Am; 1974 Sep; 58(5):1051-7. PubMed ID: 4608944
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Drug metabolism in disease.
    Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718
    [No Abstract]   [Full Text] [Related]  

  • 5. Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
    Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
    Br Med J; 1977 May; 1(6073):1384-7. PubMed ID: 861646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug metabolism in liver diseases].
    Paumgartner G
    Z Gastroenterol Verh; 1979; 16():42-7. PubMed ID: 95370
    [No Abstract]   [Full Text] [Related]  

  • 7. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of drug metabolism in polycystic non-parasitic liver disease.
    Sotaniemi EA; Luoma PV; Järvensivu PM; Sotaniemi KA
    Br J Clin Pharmacol; 1979 Oct; 8(4):331-5. PubMed ID: 508507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent findings on the hepatotoxicity of drugs].
    Altomare E; Vendemiale G; Stufano N; Di Monte D; Procacci V; Albano O
    Recenti Prog Med; 1985 Nov; 76(11):598-605. PubMed ID: 3912875
    [No Abstract]   [Full Text] [Related]  

  • 10. [Induction of drug-catabolizing enzymes in chronic alcoholics].
    Gundert-Remy U; Marquardt R; Andritsch F; Weber E
    Arch Biochem Biophys; 1974 Jan; 160(1):907-8. PubMed ID: 4828518
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug disposition in children with protein energy malnutrition.
    Mehta S
    J Pediatr Gastroenterol Nutr; 1983; 2(3):407-17. PubMed ID: 6413666
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug metabolism.
    McEwen J; Stevenson IH
    Scott Med J; 1972 Feb; 17(2):67-77. PubMed ID: 4622974
    [No Abstract]   [Full Text] [Related]  

  • 13. Overview of alkylation and peroxidation mechanisms in acute lethal hepatocellular injury by chemically reactive metabolites.
    Mitchell JR; Smith CV; Hughes H; Lauterburg BH; Horning MG
    Semin Liver Dis; 1981 May; 1(2):143-50. PubMed ID: 7347018
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism.
    Farrell GC; Cooksley WG; Hart P; Powell LW
    Gastroenterology; 1978 Oct; 75(4):580-8. PubMed ID: 710827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease.
    Hayes PC; Bouchier IA
    Am J Gastroenterol; 1989 Jul; 84(7):723-6. PubMed ID: 2741882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal drug metabolism following barbiturate and paracetamol overdosage.
    Forrest AH; Roscoe P; Stevenson IH; Prescott LF
    Scott Med J; 1974 May; 19(3):157. PubMed ID: 4829646
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage.
    Sotaniemi EA; Hokkanen OT; Ahokas JT; Pelkonen RO; Ahlqvist J
    Eur J Clin Pharmacol; 1977 Dec; 12(6):429-35. PubMed ID: 598417
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug disposition and liver disease.
    Wilkinson GR; Schenker S
    Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of biotransformation in chemical-induced liver injury.
    Mitchell JR; Snodgrass WR; Gillette JR
    Environ Health Perspect; 1976 Jun; 15():27-38. PubMed ID: 1033831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation: biochemical basis for many drug-induced liver injuries.
    Mitchell JR; Nelson SD; Thorgeirsson SS; McMurtry RJ; Dybing E
    Prog Liver Dis; 1976; 5():259-79. PubMed ID: 775543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.